J. Dogné

J. Dogné, L. Pochet, B. Châtelain, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need

B. Masereel, J. Dogné, C. Bouvy, 2019, Clinical chemistry and laboratory medicine.

Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application

J. Dogné, C. Bouvy, F. Mullier, 2019, Journal of thrombosis and haemostasis : JTH.

Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents

J. Dogné, C. Bouvy, F. Mullier, 2019, International journal of laboratory hematology.

Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review

J. Dogné, F. Mullier, V. Minet, 2017, Molecules.

Effects of leaf extracts from Croton zambesicus Müell. Arg. on hemostasis.

J. Dogné, J. Quetin-Leclercq, Séverine Robert, 2010, Journal of ethnopharmacology.

[Non-VKA oral anticoagulants: an update for the clinical biologists].

J. Dogné, M. Samama, I. Gouin-Thibault, 2015, Annales de biologie clinique.

Non-VKA Oral Anticoagulants: Accurate Measurement of Plasma Drug Concentrations

J. Dogné, B. Châtelain, F. Mullier, 2015, BioMed research international.

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays

J. Dogné, B. Châtelain, F. Mullier, 2014, Thrombosis Journal.

Edoxaban: Impact on routine and specific coagulation assays

J. Dogné, B. Châtelain, F. Mullier, 2015, Thrombosis and Haemostasis.

Facing coagulation disorders after acute trauma.

V. Deneys, J. Dogné, J. Watelet, 2016, B-ENT.

Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature.

J. Dogné, B. Châtelain, F. Mullier, 2012, Thrombosis research.

Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future

J. Dogné, T. Salmonson, Heidi Janssen, 2016, European heart journal. Cardiovascular pharmacotherapy.

Importance of measuring pharmacologically active metabolites of edoxaban: development and validation of an ultra-high-performance liquid chromatography coupled with a tandem mass spectrometry method

J. Dogné, J. Douxfils, J. Laloy, 2020, Journal of Thrombosis and Thrombolysis.

Mass spectrometry in the therapeutic drug monitoring of direct oral anticoagulants. Useful or useless

J. Dogné, L. Pochet, F. Mullier, 2016 .

Update on GPIIb/IIIa antagonists

P. Kolh, C. Supuran, J. Dogné, 2003 .

Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis

J. Dogné, C. Graux, F. Mullier, 2020, Cancers.

Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study

S. Laporte, J. Dogné, C. Chapelle, 2020, Hämostaseologie.

Proof of concept of a new scale for the harmonization and the standardization of the ETP‐based APC resistance

J. Dogné, C. Bouvy, J. Douxfils, 2020, Journal of thrombosis and haemostasis : JTH.

Analytical performance of the endogenous thrombin potential–based activated protein C resistance assay on the automated ST Genesia system

J. Dogné, J. Douxfils, A. Carlo, 2022, Research and practice in thrombosis and haemostasis.

Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay

J. Dogné, A. Lebreton, C. Bouvy, 2021, Research and practice in thrombosis and haemostasis.

Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP‐based APC resistance

J. Dogné, J. Douxfils, Marie Didembourg, 2020, International journal of laboratory hematology.

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: a retrospective study.

J. Dogné, B. Châtelain, I. Elalamy, 2013, Thrombosis research.

The role of serology for COVID-19 control: Population, kinetics and test performance do matter

J. Dogné, H. Malonne, J. Douxfils, 2020, Journal of Infection.

Platelet microparticle generation assay: a valuable test for immune heparin-induced thrombocytopenia diagnosis.

J. Dogné, B. Châtelain, I. Elalamy, 2014, Thrombosis research.

Perioperative management of patients on direct oral anticoagulants

C. Samama, J. Dogné, B. Châtelain, 2017, Thrombosis Journal.

Inhibition of tissue factor pathway inhibitor increases the sensitivity of thrombin generation assay to procoagulant microvesicles

J. Dogné, B. Châtelain, F. Mullier, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity

J. Dogné, J. Douxfils, J. Favresse, 2021, medRxiv.

Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection

J. Dogné, J. Douxfils, J. Favresse, 2021, Journal of clinical medicine.

Unexpected kinetics of anti‐SARS‐CoV‐2 total antibodies in two patients with chronic lymphocytic leukemia

J. Dogné, C. Graux, J. Douxfils, 2020, British journal of haematology.

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

J. Dogné, J. Douxfils, J. Favresse, 2022, Journal of Infection.

Clinical performance of three fully automated anti‐SARS‐CoV‐2 immunoassays targeting the nucleocapsid or spike proteins

J. Dogné, J. Douxfils, J. Favresse, 2020, Journal of medical virology.

Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates.

V. Deneys, J. Dogné, B. Châtelain, 2018, Blood transfusion = Trasfusione del sangue.

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

J. Dogné, U. Gaspard, J. Douxfils, 2021, Frontiers in Endocrinology.

Comparison of five D-dimer reagents and application of an age-adjusted cut-off for the diagnosis of venous thromboembolism in emergency department

J. Dogné, J. Jamart, B. Châtelain, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs.

C. Supuran, B. Masereel, J. Dogné, 2008, Journal of medicinal chemistry.

Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.

D. Praticò, J. Dogné, J. Hanson, 2005, Trends in pharmacological sciences.

Coxibs and cardiovascular side-effects: from light to shadow.

D. Praticò, C. Supuran, J. Dogné, 2006, Current pharmaceutical design.

New trends in dual 5-LOX/COX inhibition.

J. Dogné, B. Pirotte, F. Julémont, 2002, Current medicinal chemistry.

Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”

J. Dogné, A. Spinewine, F. Mullier, 2014, BioMed research international.

Use of paracetamol during pregnancy and child neurological development

B. Dan, J. Dogné, K. De Smet, 2015, Developmental medicine and child neurology.

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study

J. Dogné, C. Bouvy, P. Sonveaux, 2020, Frontiers in Pharmacology.

Microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia.

J. Dogné, F. Mullier, C. Chatelain, 2014, Thrombosis research.

Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1).

M. Lamy, J. Dogné, G. Deby-dupont, 2004, Biochemical and biophysical research communications.

Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study.

J. Dogné, C. Bouvy, B. Châtelain, 2017, Thrombosis research.

Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia

J. Dogné, C. Bouvy, B. Châtelain, 2017, Journal of Thrombosis and Thrombolysis.

Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.

J. Dogné, B. Châtelain, F. Mullier, 2014, Thrombosis research.

Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles

J. Dogné, F. Cecchet, B. Châtelain, 2013, Journal of extracellular vesicles.

Carbonic anhydrase inhibitors as anticonvulsant agents.

C. Supuran, B. Masereel, J. Dogné, 2007, Current topics in medicinal chemistry.

Development of injectable liposomes and drug‐in‐cyclodextrin‐in‐liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies

J. Foidart, C. Palazzo, J. Dogné, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study

J. Dogné, A. Spinewine, M. Wiesen, 2018, Thrombosis Journal.

Limited inflammatory response in rats after acute exposure to a silicon carbide nanoaerosol

B. Masereel, J. Dogné, O. Toussaint, 2015, Journal of Nanoparticle Research.

BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthase.

L. de Leval, B. Masereel, S. Rolin, 2011, Prostaglandins & other lipid mediators.

Estimation of dabigatran plasma concentrations in the perioperative setting

P. Hjemdahl, J. Dogné, B. Châtelain, 2014, Thrombosis and Haemostasis.

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

P. Hjemdahl, R. Malmström, J. Dogné, 2013, Thrombosis and Haemostasis.

Latest discoveries in prostaglandin receptor modulators

J. Dogné, B. Pirotte, P. Benoit, 2002 .

Therapeutic potential of thromboxane inhibitors in asthma

B. Masereel, S. Rolin, J. Dogné, 2002, Expert opinion on investigational drugs.

Thromboxane A2 Inhibition

B. Masereel, J. Dogné, P. Benoit, 2012, American journal of respiratory medicine : drugs, devices, and other interventions.

Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures

J. Dogné, F. Mullier, A. Larock, 2017, Expert opinion on biological therapy.

Appropriateness of Prescribing Dabigatran Etexilate and Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation

J. Dogné, A. Spinewine, F. Mullier, 2014, The Annals of pharmacotherapy.

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment

J. Dogné, J. Douxfils, J. Favresse, 2022, Clinical chemistry and laboratory medicine.

Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis

O. Feron, C. Dessy, J. Dogné, 2016, PloS one.

Bioactivity and hemocompatibility study of amorphous hydrogenated carbon coatings produced by pulsed magnetron discharge.

J. Dogné, S. Lucas, C. Michiels, 2013, Journal of biomedical materials research. Part A.

Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells.

J. Dogné, M. Bäck, C. Michiels, 2013, Biochemical and biophysical research communications.

Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant

J. Dogné, F. Mullier, J. Douxfils, 2022, Viruses.

Pre‐analytical issues in the measurement of circulating microparticles: current recommendations and pending questions

J. Dogné, B. Châtelain, F. Mullier, 2013, Journal of thrombosis and haemostasis : JTH.

The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma

J. Dogné, H. Yildiz, C. Bouvy, 2022, Research and practice in thrombosis and haemostasis.

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

W. Ageno, C. Samama, P. Verhamme, 2018, Journal of thrombosis and haemostasis : JTH.

Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.

J. Dogné, C. Bouvy, C. Chatelain, 2017, Leukemia research.

A comparison of six major platelet functional tests to assess the impact of carbon nanomaterials on platelet function: A practical guide

B. Masereel, S. Rolin, J. Dogné, 2014, Nanotoxicology.

Comparison between single-beat and multiple-beat methods for estimation of right ventricular contractility

P. Kolh, P. Segers, B. Lambermont, 2004, Critical care medicine.

Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.

J. Dogné, C. Bouvy, F. Mullier, 2022, Seminars in thrombosis and hemostasis.

Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.

J. Dogné, C. Bouvy, F. Mullier, 2022, Seminars in thrombosis and hemostasis.

Effect of BM-573 [N-Terbutyl-N′-[2-(4′-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, in a Porcine Model of Acute Pulmonary Embolism

P. Kolh, P. Segers, B. Lambermont, 2004, Journal of Pharmacology and Experimental Therapeutics.

Effect of BM-573, a dual thromboxane synthase inhibitor and TP receptor antagonist, in a porcine model of acute pulmonary embolism

P. Kolh, P. Segers, B. Lambermont, 2004 .

BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2alphain vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents.

D. Praticò, B. Masereel, S. Rolin, 2007, Prostaglandins & other lipid mediators.

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry.

J. Dogné, B. Châtelain, F. Mullier, 2014, Thrombosis research.

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

J. Dogné, C. Graux, F. Mullier, 2017, Expert opinion on drug safety.

Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors.

B. Masereel, S. Rolin, J. Dogné, 2004, Prostaglandins & other lipid mediators.

Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data

S. Laporte, J. Dogné, C. Chapelle, 2020, Data in Brief.

An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants.

J. Dogné, A. Spinewine, L. Pochet, 2017, Thrombosis research.

Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma

J. Dogné, C. Bouvy, L. Pochet, 2019, International journal of laboratory hematology.

Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study.

P. Hjemdahl, J. Dogné, P. Wallemacq, 2015, Thrombosis research.

Platelet microparticle generation assay

J. Dogné, B. Châtelain, I. Elalamy, 2013 .

Are the DOAC plasma level thresholds appropriate for clinical decision‐making? A reappraisal using thrombin generation testing

J. Dogné, F. Mullier, J. Douxfils, 2020, International journal of laboratory hematology.

Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels.

J. Dogné, F. Mullier, J. Douxfils, 2017, Thrombosis research.

Optimizing the Safe Use of Direct Oral Anticoagulants in Older Patients: A Teachable Moment.

J. Dogné, A. Spinewine, A. Sennesael, 2015, JAMA internal medicine.

Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study.

J. Dogné, B. Châtelain, F. Mullier, 2015, Thrombosis research.

AB0223 Evaluation of classical nsaids and cox-2 selective inhibitors on purified ovine enzymes and human whole blood

B. Masereel, J. Dogné, Y. Henrotin, 2001, Prostaglandins, leukotrienes, and essential fatty acids.

Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization

J. Dogné, J. Yombi, P. Wallemacq, 2020, European Journal of Drug Metabolism and Pharmacokinetics.

Model informed dosing of hydroxycholoroquine in COVID‐19 patients: Learnings from the recent experience, remaining uncertainties and gaps

J. Dogné, D. Konopnicki, M. Payen, 2020, British journal of clinical pharmacology.

Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pig.

P. Kolh, P. Segers, B. Lambermont, 2005, Thrombosis research.

Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.

C. Supuran, A. Casini, A. Scozzafava, 2004, Journal of medicinal chemistry.

In Vitro and in Vivo Pharmacological Characterization of BM-613 [N-n-Pentyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a Novel Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist

B. Masereel, S. Rolin, J. Dogné, 2005, Journal of Pharmacology and Experimental Therapeutics.

In vitro and in vivo pharmacological characterization of BM-613, a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist

B. Masereel, S. Rolin, J. Dogné, 2004 .

Pharmacological Characterization of N-tert-Butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a Novel Thromboxane A2 Receptor Antagonist and Thromboxane Synthase Inhibitor in a Rat Model of Arterial Thrombosis and Its Effects on Bleeding Time

P. Kolh, P. Segers, L. de Leval, 2004, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological characterization of BM-573, a novel thromboxane A 2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time

P. Kolh, P. Segers, B. Masereel, 2004 .

Effects of endotoxic shock on right ventricular systolic function and mechanical efficiency.

P. Kolh, P. Segers, B. Lambermont, 2003, Cardiovascular research.

The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review

J. Dogné, B. Châtelain, F. Mullier, 2014, Journal of extracellular vesicles.

Prospective and comparative study of paroxysmal nocturnal hemoglobinuria patients treated or not by eculizumab

J. Dogné, B. Châtelain, F. Mullier, 2019, Medicine.

Focus on platelet extracellular vesicles

J. Dogné, B. Châtelain, F. Mullier, 2019 .

Multiple Causes of Cardiotoxic Effects in Patients With Chronic Myeloid Leukemia-Reply.

J. Dogné, J. Douxfils, Hélène Haguet, 2016, JAMA oncology.

Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review

J. Dogné, B. Châtelain, F. Mullier, 2015, European journal of haematology.

The euglobulin clot lysis time to assess the impact of nanoparticles on fibrinolysis

J. Dogné, O. Toussaint, S. Lucas, 2015, Journal of Nanoparticle Research.

Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster

J. Dogné, J. Douxfils, J. Favresse, 2022, Journal of medical virology.

Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster

J. Dogné, J. Douxfils, J. Favresse, 2022, Clinical chemistry and laboratory medicine.

Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory

J. Dogné, F. Mullier, J. Douxfils, 2020, International journal of laboratory hematology.

Anticonvulsant Activity of Pyrid‐3‐yl‐Sulfonyl Ureas and Thioureas

J. Poupaert, B. Masereel, J. Dogné, 1997, Epilepsia.

Dose tailoring of dabigatran etexilate: obvious or excessive?

J. Dogné, F. Mullier, J. Douxfils, 2015, Expert opinion on drug safety.

Criteria for Prescribing Dabigatran Etexilate and Rivaroxaban Really Appropriate? Authors’ Reply

J. Dogné, A. Spinewine, F. Mullier, 2015, The Annals of pharmacotherapy.

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients

J. Dogné, J. Douxfils, J. Favresse, 2020, Clinical chemistry and laboratory medicine.

Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.

J. Dogné, C. Bouvy, F. Mullier, 2022, Seminars in thrombosis and hemostasis.

Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment

J. Dogné, B. Châtelain, F. Mullier, 2015, Journal of thrombosis and haemostasis : JTH.

Namur Real-world variability in dabigatran levels in patients with atrial fibrillation

J. Dogné, B. Châtelain, F. Mullier, 2015 .

Neutralization of biotin interference: preliminary evaluation of the VeraTest Biotin™, VeraPrep Biotin™ and BioT-Filter®

J. Dogné, D. Gruson, J. Douxfils, 2020, Clinical chemistry and laboratory medicine.

Recent development in the field of dual COX / 5-LOX inhibitors.

J. Dogné, X. de Leval, B. Pirotte, 2004, Mini reviews in medicinal chemistry.

Quantification and characterization of microvesicles: Applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer

J. Dogné, B. Châtelain, F. Mullier, 2012 .

Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition.

B. Norberg, J. Wouters, B. Masereel, 2000, Acta crystallographica. Section C, Crystal structure communications.

Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels.

J. Dogné, Y. Gruel, F. Mullier, 2021, Haematologica.

Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban‐treated patients and healthy controls

J. Dogné, H. Yildiz, C. Bouvy, 2022, Research and practice in thrombosis and haemostasis.

Impact of the Direct Oral Anticoagulants on Activated Clotting Time.

J. Dogné, B. Châtelain, F. Mullier, 2017, Journal of cardiothoracic and vascular anesthesia.

Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles.

B. Masereel, S. Rolin, J. Dogné, 2001, Prostaglandins, leukotrienes, and essential fatty acids.

Synthesis, structural characterization and thromboxane A2 receptor antagonistic activity of 3-substituted 2-[(arylsulfonyl)imino]-2,3-dihydrothiazolyl derivatives

B. Masereel, J. Dogné, J. Leger, 1999 .

Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitor.

P. Kolh, P. Chiap, B. Lambermont, 2006, Cardiovascular drug reviews.

Recent developments of thromboxane modulators

B. Masereel, J. Dogné, J. Delarge, 2001 .

INT-001 Appropriateness of prescribing direct oral anticoagulants: a prospective study

J. Dogné, A. Spinewine, F. Mullier, 2015 .

Appropriateness of prescribing of direct oral anticoagulants: a prospective study.

J. Dogné, A. Spinewine, F. Mullier, 2013 .

Cardiovascular haemodynamics and ventriculo‐arterial coupling in an acute pig model of coronary ischaemia–reperfusion

P. Kolh, P. Verdonck, P. Segers, 2007, Experimental physiology.

Remodeling and Repair in Rhinosinusitis

J. Watelet, J. Dogné, F. Mullier, 2015, Current Allergy and Asthma Reports.

Recruitment and activation of circulating neutrophils after sinus surgery.

J. Dogné, J. Watelet, B. Châtelain, 2015, B-ENT.

Development and validation of a liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of serotonin and thromboxane B2 from activated platelets

J. Dogné, L. Pochet, F. Mullier, 2018, International journal of laboratory hematology.

Betrixaban: Impact on Routine and Specific Coagulation Assays—A Practical Laboratory Guide

J. Dogné, L. Pochet, B. Châtelain, 2018, Thrombosis and Haemostasis.

Alteration of left ventriculo-arterial coupling and mechanical efficiency during acute myocardial ischemia.

P. Kolh, B. Lambermont, J. Dogné, 2003, International angiology : a journal of the International Union of Angiology.

Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation.

M. Merville, V. Benoît, B. Masereel, 2003, Prostaglandins, leukotrienes, and essential fatty acids.

Confirmation of High Cytokine Clearance by Hemofiltration with a Cellulose Triacetate Membrane with Large Pores: An in vivo Study

P. Kolh, B. Lambermont, J. Dogné, 2006, The International journal of artificial organs.

Effect of a Novel Thromboxane A2 Inhibitor on Right Ventricular-Arterial Coupling in Endotoxic Shock

P. Kolh, P. Segers, B. Lambermont, 2004, Shock.

New trends in thromboxane and prostacyclin modulators.

B. Masereel, J. Dogné, J. David, 2000, Current medicinal chemistry.

Effects of a novel non-carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function.

S. Rolin, J. Dogné, J. David, 2000, Prostaglandins, leukotrienes, and essential fatty acids.

A Rapid, Practical and Ergonomic Device to Prepare Plasma Sample Free of Platelets and Direct Oral Anticoagulant for Routine Hemostasis Tests

J. Dogné, C. Bouvy, J. Douxfils, 2019 .

More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry‐based quantification of biological microparticles

J. Dogné, B. Châtelain, F Mullier, 2011, Journal of thrombosis and haemostasis : JTH.

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

J. Dogné, C. Graux, F. Mullier, 2018, TH Open.

Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors.

J. Wouters, G. Rondelet, J. Dogné, 2016, European journal of medicinal chemistry.

Synthesis and structural studies of 3-alkylamino-pyrido[4,3-e]-1,2,4- thiadiazine 1,1-dioxides: A new class of heterocyclic compounds with therapeutical promises

P. Tullio, J. Dogné, B. Pirotte, 1999 .

Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)

J. Dogné, P. Bahri, S. Straus, 2020, Drug Safety.

Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells.

Antony E. Fernandes, O. Feron, A. Marchand, 2013, Bioorganic & medicinal chemistry.

Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors.

B. Masereel, C. Bertolla, J. Dogné, 2008, Journal of medicinal chemistry.

Adverse cardiovascular effects of the coxibs.

D. Praticò, C. Supuran, J. Dogné, 2005, Journal of medicinal chemistry.

A new potential cyclooxygenase-2 inhibitor, pyridinic analogue of nimesulide.

J. Dogné, C. Charlier, C. Michaux, 2005, European journal of medicinal chemistry.

Clustering and Kernel Density Estimation for Assessment of Measurable Residual Disease by Flow Cytometry

Jean-Michel Dogné, Bernard Chatelain, François Mullier, 2020, Diagnostics.

Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A₂ receptor antagonists.

P. Kolh, J. Dogné, B. Pirotte, 2013, European journal of medicinal chemistry.

Synthesis and biological evaluation of sulfonylcyanoguanidines and sulfonamidonitroethylenes as bioisosteres of hypoglycemic sulfonylureas

P. Tullio, B. Masereel, J. Dogné, 1997 .

An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens

J. Dogné, J. Douxfils, J. Favresse, 2020, Journal of clinical medicine.

Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study

J. Dogné, J. Douxfils, J. Favresse, 2020, Clinical chemistry and laboratory medicine.

New trends in anti-malarial agents.

L. Angenot, J. Dogné, M. Frédérich, 2002, Current medicinal chemistry.

Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitors.

C. Supuran, J. Wouters, B. Masereel, 2009, European journal of medicinal chemistry.

Solid lipid microparticles as a sustained release system for pulmonary drug delivery.

L. Delattre, J. Dogné, B. Evrard, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature

J. Dogné, J. Douxfils, J. Favresse, 2021, Vaccines.

Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody

Marie Tré-Hardy, Alain Wilmet, Ingrid Beukinga, 2020, Clinical chemistry and laboratory medicine.

Characterization of core/shell Cu/Ag nanopowders synthesized by electrochemistry and assessment of their impact on hemolysis, platelet aggregation, and coagulation on human blood for potential wound dressing use

J. Dogné, P. Fricoteaux, V. Mancier, 2017, Journal of Nanoparticle Research.

Design, synthesis, and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors.

J. Winum, J. Montero, J. Dogné, 2004, Journal of medicinal chemistry.

Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors.

J. Dogné, C. Charlier, C. Michaux, 2002, Journal of medicinal chemistry.

A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors.

J. Wouters, B. Masereel, S. Rolin, 2003, European journal of medicinal chemistry.

Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”

J. Dogné, A. Spinewine, F. Mullier, 2014, BioMed research international.

Recent developments in 5lipoxygenase inhibitors

J. Dogné, B. Pirotte, F. Julémont, 2003 .

Recent developments in 5-lipoxygenase inhibitors

J. Dogné, B. Pirotte, F. Julémont, 2003 .

Characterisation of tissue factor-bearing extracellular vesicles with AFM: comparison of air-tapping-mode AFM and liquid Peak Force AFM

Bernard Chatelain, François Mullier, Francesca Cecchet, 2013, Journal of extracellular vesicles.

Validation and assessment of mepacrine testing in delta storage pool disease: A 3-centre study

J. Dogné, T. Lecompte, B. Châtelain, 2012 .

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

G. Lippi, R. Medcalf, J. Dogné, 2020, Thrombosis Journal.

Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action.

C. Supuran, B. Masereel, J. Dogné, 2008, Current pharmaceutical design.

Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies

J. Dogné, J. Douxfils, J. Favresse, 2020, Clinical chemistry.

Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation.

P. Lambin, L. Dubois, A. Harris, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors.

Johan Wouters, Bernard Masereel, Alessandro Cecchi, 2009, Bioorganic & medicinal chemistry.

Understanding thrombosis with thrombocytopenia syndrome after COVID-19 vaccination

M. Borad, S. Kochanek, J. Dogné, 2022, npj Vaccines.

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments

J. Dogné, F. Mullier, J. Douxfils, 2021, Frontiers in Pharmacology.

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers

J. Dogné, V. Gérin, F. Mullier, 2021, Vaccines.

First and second generations of COX-2 selective inhibitors.

V. Benoît, J. Dogné, M. Frédérich, 2004, Mini reviews in medicinal chemistry.

Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs?

Bernard Pirotte, Bernard Masereel, B. Masereel, 2009, Pharmacological research.

Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study

J. Dogné, C. Bouvy, C. Graux, 2018, Biomarkers in cancer.

Safety monitoring of COVID‐19 vaccines: perspective from the European Medicines Agency

J. Dogné, G. Genov, C. Cohet, 2022, Clinical pharmacology and therapeutics.

Human papillomavirus vaccines: Understanding the benefit–risk

M. Van Ranst, P. van Damme, J. Dogné, 2013, Annals of medicine.

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting

J. Dogné, F. Mullier, J. Douxfils, 2014, BioMed research international.

Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study

J. Dogné, A. Spinewine, F. Verschuren, 2018, British journal of clinical pharmacology.

Can TiC nanoparticles produce toxicity in oral administration to rats?

B. Masereel, J. Dogné, O. Toussaint, 2014, Toxicology reports.

Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.

C. Supuran, A. Casini, A. Scozzafava, 2005, Journal of medicinal chemistry.

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

J. Dogné, J. Douxfils, J. Favresse, 2021, Viruses.

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection

J. Dogné, J. Douxfils, J. Favresse, 2021, Microorganisms.

Characterization of water-based paints containing titanium dioxide or carbon black as manufactured nanomaterials before and after atomization

J. Dogné, S. Lucas, U. Uhrner, 2019, Applied Nanoscience.

Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis.

J. Dogné, C. Graux, F. Mullier, 2016, JAMA oncology.

The Effect of Clonidine, an Alpha-2 Adrenergic Receptor Agonist, on Inflammatory Response and Postischemic Endothelium Function During Early Reperfusion in Healthy Volunteers

J. Dogné, J. Jamart, B. Châtelain, 2012, Journal of cardiovascular pharmacology.

Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice.

D. Praticò, J. Dogné, T. Cyrus, 2007, Blood.

Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.

C. Supuran, Alessandro Cecchi, J. Wouters, 2006, Journal of medicinal chemistry.

Indanesulfonamides as carbonic anhydrase inhibitors and anticonvulsant agents: structure-activity relationship and pharmacological evaluation.

C. Supuran, A. Scozzafava, D. Vullo, 2008, European journal of medicinal chemistry.

Exploration of the Binding Mode of Indanesulfonamides as Selective Inhibitors of Human Carbonic Anhydrase Type VII by Targeting Lys 91

C. Supuran, J. Wouters, B. Masereel, 2007, ChemMedChem.

Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials

Catherine Y. Marbehant, B. Masereel, S. Rolin, 2012, Nanotoxicology.

Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.

C. Supuran, A. Scozzafava, J. Winum, 2007, Bioorganic & Medicinal Chemistry Letters.

Large-pore membrane hemofiltration increases cytokine clearance and improves right ventricular-vascular coupling during endotoxic shock in pigs.

Thomas Desaive, Pierre Delanaye, Bernard Lambermont, 2006, Artificial organs.

Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor

J. Wouters, B. Masereel, J. Dogné, 2001, The Journal of pharmacy and pharmacology.

From the design to the clinical application of thromboxane modulators.

Bernard Pirotte, Pierre Drion, D. Praticò, 2006, Current pharmaceutical design.

EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection

J. Dogné, J. Slattery, F. Domergue, 2018, Drug Safety.

thromboxane A2 suppression in LDLR KO mice Thromboxane receptor blockade improves the antiatherogenic effect of

D. Praticò, J. Dogné, T. Cyrus, 2013 .

suppression in LDLR KO mice 2 thromboxane A Thromboxane receptor blockade improves the antiatherogenic effect of

D. Praticò, J. Dogné, T. Cyrus, 2010 .

Vascular biology of eicosanoids and atherogenesis

D. Praticò, J. Dogné, 2009, Expert review of cardiovascular therapy.

A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice.

D. Praticò, J. Dogné, T. Cyrus, 2007, European journal of pharmacology.

Selective Cyclooxygenase-2 Inhibitors Development in Cardiovascular Medicine

D. Praticò, J. Dogné, 2005, Circulation.

Recent advances in antiplatelet agents.

B. Masereel, J. Dogné, J. David, 2002, Current Medicinal Chemistry.

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation

J. Dogné, S. Straus, P. Martelletti, 2018, The Journal of Headache and Pain.

Antibody titres decline 3-month post-vaccination with BNT162b2

J. Dogné, F. Mullier, J. Douxfils, 2021, Emerging microbes & infections.

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing

J. Dogné, J. Douxfils, J. Favresse, 2023, Clinical chemistry and laboratory medicine.

Multimodality imaging assessment of the deleterious role of the intraluminal thrombus on the growth of abdominal aortic aneurysm in a rat model

M. Bahri, A. Plenevaux, N. Withofs, 2016, European Radiology.

Perceived high risk of COVID-19 vaccination: The revealing power of placebo

P. van Damme, J. Dogné, D. Ebo, 2023, The Journal of Allergy and Clinical Immunology: In Practice.

New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators.

B. Masereel, J. Dogné, J. David, 2004, Current medicinal chemistry.

New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators.

P. Kolh, A. Casini, B. Lambermont, 2004, Current medicinal chemistry.

Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function.

P. Kolh, B. Masereel, S. Rolin, 2003, Prostaglandins, leukotrienes, and essential fatty acids.

Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531.

P. Kolh, B. Masereel, S. Rolin, 2006, Cardiovascular drug reviews.

Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition.

J. Wouters, B. Masereel, S. Rolin, 2001, Bioorganic & medicinal chemistry letters.

Effects of BM-573, a Novel Thromboxane A2 Inhibitor, on Pulmonary Hemodynamics in Endotoxic Shock

P. Kolh, B. Lambermont, B. Masereel, 2003, Archives of physiology and biochemistry.

Effects of U-46619 on Pulmonary Hemodynamics Before and After Administration of BM-573, a Novel Thromboxane A2 Inhibitor

P. Kolh, B. Lambermont, B. Masereel, 2003, Archives of physiology and biochemistry.

Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsus

G. Cornelis, J. Dogné, J. Douxfils, 2017, Journal of thrombosis and haemostasis : JTH.

Advances in the field of COX-2 inhibition

J. Dogné, B. Pirotte, F. Julémont, 2002 .

BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis on the Risk of Cardiovascular Events, Major Molecular Response and Overall Survival

J. Dogné, C. Graux, C. Chatelain, 2015 .

Suitability of analytical methods to measure solubility for the purpose of nanoregulation

Julie Laloy, Ratna Tantra, Hans Bouwmeester, 2015, Nanotoxicology.

Effects of SiC nanoparticles orally administered in a rat model: biodistribution, toxicity and elemental composition changes in feces and organs.

B. Masereel, S. Rolin, J. Dogné, 2012, Toxicology and applied pharmacology.

Quantification of nanoparticles in aqueous food matrices using Particle-Induced X-ray Emission

Jorge Mejia, Olivier Toussaint, Tijani Tabarrant, 2012, Analytical and Bioanalytical Chemistry.

Cardiovascular effect of BCR-ABL TKIs: a meta-analysis and systematic review of arterial and venous occlusive events

J. Dogné, C. Graux, F. Mullier, 2016 .

Perceived high risk of COVID-19 vaccination: The revealing power of placebo

P. van Damme, J. Dogné, D. Ebo, 2023, The Journal of Allergy and Clinical Immunology: In Practice.

Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies

Marie Tré-Hardy, Alain Wilmet, Ingrid Beukinga, 2020, Journal of medical virology.

BM-573, a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, Prevents Pig Myocardial Infarction Induced by Coronary Thrombosis

M Petein, P. Kolh, B. Lambermont, 2003, Journal of Pharmacology and Experimental Therapeutics.

A dual thromboxane inhibitor and thromboxane receptor antagonist prevents pig myocardial infarction induced by coronary thrombosis

P. Kolh, B. Lambermont, B. Masereel, 2003 .

Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks

H. Goossens, P. Maes, M. Van Ranst, 2023, Nature Aging.

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

J. Dogné, F. Mullier, J. Douxfils, 2021, Clinical Microbiology and Infection.

Solubility Part 1: Overview

Kenneth N. Robinson, H. Bouwmeester, J. Dogné, 2016 .

Impact of functional inorganic nanotubes f-INTs-WS2 on hemolysis, platelet function and coagulation

J. Dogné, J. Lellouche, D. Raichman, 2018, Nano Convergence.

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects

J. Dogné, J. Douxfils, J. Favresse, 2021, Viruses.

New developments on thromboxane modulators.

P. Kolh, B. Masereel, J. Dogné, 2004, Mini reviews in medicinal chemistry.

Platelet ADP receptors and their antagonists.

J. Dogné, P. Benoit, 2003, Mini reviews in medicinal chemistry.

A conceptual approach to the masking effect of measures of disproportionality

Manfred Hauben, M. Hauben, J. Dogné, 2014, Pharmacoepidemiology and drug safety.

Platelet microparticle generation assay for heparin-induced thrombocytopenia diagnosis: How should we express the results?

J. Dogné, F. Mullier, N. Bailly, 2015, Thrombosis research.

Antibody titers decline 3-month post-vaccination with BNT612b2

J. Dogné, F. Mullier, J. Douxfils, 2021 .

Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2

J. Dogné, V. Gérin, F. Mullier, 2021, Microorganisms.

Fast, asymmetric and nonhomogeneous clearance of SiC nanoaerosol assessed by micro-particle-induced x-ray emission.

J. Dogné, S. Lucas, J. Laloy, 2018, Nanomedicine.

Synthesis, Structural Characterization and Thromboxane A2 Receptor Antagonistic Activity of 3-Substituted 2-[(Arylsulfonyl)imino]-2,3-dihydrothiazolyl Derivatives.

B. Masereel, J. Dogné, J. Leger, 1999 .

A mathematical framework to quantify the masking effect associated with the confidence intervals of measures of disproportionality

Manfred Hauben, M. Hauben, J. Dogné, 2017, Therapeutic advances in drug safety.

Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases

M. Hauben, J. Dogné, F. Maignen, 2014, Pharmacoepidemiology and drug safety.

Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome

J. Dogné, F. Mullier, J. Douxfils, 2022, Vaccines.

Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee

G. Rasi, J. Dogné, J. Raine, 2014, Nature Reviews Drug Discovery.

Moving Toward a Question‐Centric Approach for Regulatory Decision Making in the Context of Drug Assessment

P. Colin, J. Dogné, A. Ceci, 2023, Clinical pharmacology and therapeutics.

Modulation of the arachidonic cascade with omega3 fatty acids or analogues: potential therapeutic benefits.

L. Delattre, J. Dogné, B. Evrard, 2004, Mini reviews in medicinal chemistry.

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies

J. Dogné, D. Gruson, J. Douxfils, 2020, Clinical Biochemistry.

Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.

C. Supuran, A. Scozzafava, A. Innocenti, 2008, Journal of medicinal chemistry.

Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration

J. Dogné, J. Douxfils, J. Favresse, 2023, Clinical chemistry and laboratory medicine.

PEGylated and Functionalized Aliphatic Polycarbonate Polyplex Nanoparticles for Intravenous Administration of HDAC5 siRNA in Cancer Therapy.

Denis Mottet, E. Hendrick, A. Frère, 2017, ACS applied materials & interfaces.

Recent advances in inducible cyclooxygenase (COX-2) inhibition.

J Delarge, J. Dogné, Y. Henrotin, 2000, Current medicinal chemistry.

Thrombin Generation Assay Is Superior to Traditional Coagulometric and Chromogenic Assays to Monitor New Oral Anticoagulants

J. Dogné, B. Châtelain, F. Mullier, 2012 .

Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis.

J. Dogné, C. Graux, F. Mullier, 2016, JAMA oncology.

An optimized dRVVT-based assay to estimate the intensity of anticoagulation in patients treated with direct oral anticoagulants.

J. Dogné, A. Spinewine, L. Pochet, 2017, Thrombosis research.

Dose tailoring of dabigatran etexilate: obvious or excessive?

J. Dogné, F. Mullier, J. Douxfils, 2015, Expert opinion on drug safety.

Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study.

P. Hjemdahl, J. Dogné, P. Wallemacq, 2015, Thrombosis research.

Contribution of platelet microparticles generation assay to the diagnosis of type II heparin-induced thrombocytopenia

J. Dogné, B. Châtelain, F. Mullier, 2010, Thrombosis and Haemostasis.

A conceptual approach to the masking effect of measures of disproportionality

M. Hauben, J. Dogné, F. Maignen, 2014, Pharmacoepidemiology and drug safety.

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

P. Hjemdahl, R. Malmström, J. Dogné, 2013, Thrombosis and Haemostasis.

Posters Abstracts

J. Dogné, C. Bouvy, J. Douxfils, 2019, Research and Practice in Thrombosis and Haemostasis.

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone

J. Foidart, J. Dogné, U. Gaspard, 2022, Journal of Clinical Endocrinology and Metabolism.

A comparison of six major platelet functional tests to assess the impact of carbon nanomaterials on platelet function: A practical guide

B. Masereel, S. Rolin, J. Dogné, 2014, Nanotoxicology.

Synthesis and structural studies of 3-alkylamino-pyrido[4,3-e]-1,2,4- thiadiazine 1,1-dioxides: A new class of heterocyclic compounds with therapeutical promises

P. Tullio, J. Dogné, B. Pirotte, 1999 .

An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance

J. Dogné, Benjamin Micallef, A. Serracino-Inglott, 2023, Drug Safety.